Brief: ORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat

ORYZON Genomics SA

13/01/2025 14:29

Jan 13 (Reuters) - Oryzon Genomics SA  ORY.MC :
    * ORYZON ANNOUNCES FIRST PATIENT DOSED IN NCI-SPONSORED
IADADEMSTAT IN COMBINATION WITH VENETOCLAX AND AZACITIDINE
CLINICAL TRIAL IN FIRST LINE ACUTE MYELOID LEUKEMIA

Source text:  ID:nGNX8srrBv 
Further company coverage:  ORY.MC 

 ((Reuters.Briefs@thomsonreuters.com;))